STOCKWATCH

Sun Pharmaceutical to Invest INR 3,000 Crores in Greenfield Formulations Manufacturing Facility

Sun Pharmaceutical Industries Ltd has announced that its wholly-owned subsidiary, Sun Pharma Laboratories Limited, will invest INR 3,000 crores in a new Greenfield project. The project involves setting up a formulations manufacturing facility in Madhya Pradesh. This information was disclosed in a regulatory filing made by the company to the National Stock Exchange of India and BSE Limited.

• Sun Pharma Laboratories Limited, a wholly-owned subsidiary of Sun Pharmaceutical Industries Ltd, will invest INR 3,000 crores in a Greenfield project.
• The project is a formulations manufacturing facility in Madhya Pradesh.
• The announcement was made in a regulatory filing to the National Stock Exchange of India and BSE Limited.